ONTOLOGY REPORT - ANNOTATIONS
| Term: | mechlorethamine |
|
| Accession: | CHEBI:28925
|
browse the term
|
| Definition: | A nitrogen mustard that has formula C5H11Cl2N. |
| Synonyms: | exact_synonym: | 2-chloro-N-(2-chloroethyl)-N-methylethanamine |
| | related_synonym: | 2,2'-dichloro-N-methyldiethylamine; C5H11Cl2N; CN(CCCl)CCCl; InChI=1S/C5H11Cl2N/c1-8(4-2-6)5-3-7/h2-5H2,1H3; InChIKey=HAWPXGHAZFHHAD-UHFFFAOYSA-N; N-methyl-bis(2-chloroethyl)amine; N-methyl-bis(beta-chloroethyl)amine; beta,beta'-dichlorodiethyl-N-methylamine; bis(2-chloroethyl)methylamine; bis(beta-chloroethyl)methylamine; chlormethine; methylbis(2-chloroethyl)amine; methylbis(beta-chloroethyl)amine; nitrogen mustard |
| | alt_id: | CHEBI:25557; CHEBI:6708 |
| | xref_casrn: | 51-75-2 |
| | xref: | ChEMBL:101470 "ChEMBL COMPOUND"; ChemIDplus:51-75-2 "CAS Registry Number"; DrugBank:DB00888 "DrugBank"; KEGG COMPOUND:51-75-2 "CAS Registry Number"; KEGG COMPOUND:C07115 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D008466 |
| | xref: | NIST Chemistry WebBook:51-75-2 "CAS Registry Number"; Wikipedia:Mechlorethamine "Wikipedia" |
|
|
mechlorethamine
|
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
increases expression |
ISO |
X |
134,868,878 |
134,908,166 |
RGD:6480464 |
CTD |
| G |
Ampd3 |
adenosine monophosphate deaminase 3 |
|
increases expression |
ISO |
1 |
168,519,462 |
168,568,291 |
RGD:6480464 |
CTD |
| G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
decreases expression |
ISO |
13 |
88,258,993 |
88,283,918 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Calm3 |
calmodulin 3 |
|
decreases expression |
ISO |
1 |
77,245,609 |
77,252,717 |
RGD:6480464 |
CTD |
| G |
Casp2 |
caspase 2 |
|
increases activity |
ISO |
4 |
70,029,728 |
70,047,164 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
multiple interactions |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
increases stability |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
decreases activity |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
multiple interactions |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
multiple interactions |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
decreases activity |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases stability |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
multiple interactions |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
increases activity |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Cxcr2 |
chemokine (C-X-C motif) receptor 2 |
|
affects response to substance |
ISO |
9 |
73,470,943 |
73,477,315 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
increases expression |
ISO |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
decreases expression |
ISO |
10 |
87,219,157 |
87,242,919 |
RGD:6480464 |
CTD |
| G |
Gdf9 |
growth differentiation factor 9 |
|
increases expression |
ISO |
10 |
38,899,125 |
38,903,073 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
decreases response to substance |
ISO |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
ISO |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
decreases response to substance |
EXP |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
decreases response to substance |
EXP |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Jag1 |
jagged 1 |
|
increases expression |
ISO |
3 |
125,181,063 |
125,216,481 |
RGD:6480464 |
CTD |
| G |
Lamc2 |
laminin, gamma 2 |
|
decreases expression |
ISO |
13 |
68,151,074 |
68,211,117 |
RGD:6480464 |
CTD |
| G |
Lamc2 |
laminin, gamma 2 |
|
increases degradation |
ISO |
13 |
68,151,074 |
68,211,117 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mobp |
myelin-associated oligodendrocyte basic protein |
|
decreases expression |
ISO |
8 |
125,118,618 |
125,144,099 |
RGD:6480464 |
CTD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
affects response to substance |
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:6480464 |
CTD |
| G |
Nckap1 |
NCK-associated protein 1 |
|
decreases expression |
ISO |
3 |
63,191,700 |
63,274,021 |
RGD:6480464 |
CTD |
| G |
Ndrg2 |
NDRG family member 2 |
|
decreases expression |
ISO |
15 |
27,338,552 |
27,347,196 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
decreases response to substance |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nmu |
neuromedin U |
|
increases expression |
ISO |
14 |
34,115,472 |
34,143,662 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Pdcd4 |
programmed cell death 4 |
|
increases expression |
ISO |
1 |
260,183,648 |
260,202,032 |
RGD:6480464 |
CTD |
| G |
Plp1 |
proteolipid protein 1 |
|
decreases expression |
ISO |
X |
124,488,627 |
124,503,639 |
RGD:6480464 |
CTD |
| G |
Polr2j |
polymerase (RNA) II (DNA directed) polypeptide J |
|
decreases expression |
ISO |
12 |
21,658,406 |
21,663,958 |
RGD:6480464 |
CTD |
| G |
Psmd11 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 |
|
increases expression |
ISO |
10 |
68,664,950 |
68,710,616 |
RGD:6480464 |
CTD |
| G |
Psmd7 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 7 |
|
increases expression |
ISO |
19 |
37,452,152 |
37,459,440 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Shfm1 |
split hand/foot malformation (ectrodactyly) type 1 |
|
increases expression |
ISO |
4 |
31,316,084 |
31,336,240 |
RGD:6480464 |
CTD |
| G |
Stk11 |
serine/threonine kinase 11 |
|
increases expression |
ISO |
7 |
11,086,760 |
11,103,522 |
RGD:6480464 |
CTD |
| G |
Tnfrsf12a |
tumor necrosis factor receptor superfamily, member 12a |
|
decreases expression |
ISO |
10 |
12,940,334 |
12,942,343 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
affects response to substance |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Ube2k |
ubiquitin-conjugating enzyme E2K |
|
increases expression |
ISO |
14 |
45,349,287 |
45,411,823 |
RGD:6480464 |
CTD |
Term paths to the root
|